News from anthera pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 14, 2011, 17:00 ET

Anthera Announces Completion of Safety Review by DSMB for VISTA-16

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Dec 05, 2011, 17:00 ET

Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing therapeutics to treat serious diseases associated with...

Dec 01, 2011, 08:00 ET

Anthera Pharmaceuticals Completes Interim B-Cell Analysis of PEARL-SC Study

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Nov 01, 2011, 16:15 ET

Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended September 30, 2011....

Oct 25, 2011, 16:30 ET

Anthera Announces Last Patient Enrolled in PEARL-SC Study

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Oct 24, 2011, 21:00 ET

Anthera Announces Third Quarter 2011 Financial Report and Conference Call

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Sep 08, 2011, 16:39 ET

Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Jul 29, 2011, 08:00 ET

Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2011....

Jun 08, 2011, 16:00 ET

Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public offering of...

Jun 03, 2011, 09:00 ET

Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 6,666,667 shares of its common...

Jun 02, 2011, 16:00 ET

Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it intends to offer and sell shares of its common stock in an underwritten...

May 03, 2011, 17:00 ET

Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2011....

Apr 18, 2011, 08:00 ET

Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Feb 24, 2011, 17:00 ET

Anthera Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...

Feb 23, 2011, 17:00 ET

Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Feb 23, 2011, 08:00 ET

Anthera Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter and year ended December 31,...

Feb 08, 2011, 17:00 ET

Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...

Feb 01, 2011, 17:00 ET

Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...

Jan 06, 2011, 17:00 ET

Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Dec 14, 2010, 16:15 ET

Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with abnormal...